Join Mailing List   |   Print Page   |   Contact Us   |   Sign In   |   Join
Thrombosis and Haemostasis Volume 61 - Volume 70
Share |

Thrombosis and Haemostasis

Vol 70 (1993)

Zacharski LR, Donati MB, Rickles FR. Registry of Clinical Trials of Antithrombotic Drugs in Cancer: Second Report. Thromb Haemost 1993; 70: 357-60.

Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M. Antithrombin III Mutation Database: First Update. Thromb Haemost 1993; 70: 361-9.

Falanga A, Barbui T, Rickles FR, Levine MN. Guidelines for Clotting Studies in Cancer Patients. Thromb Haemost 1993; 70: 540-2.

Barrowcliffe TW. Factor VIII and Factor IX Sub-Committee Recommendations for the Assay of High Purity Factor VIII Concentrates. Thromb Haemost 1993; 70: 876-77.

Vol 69 (1993)

Reitsma PH, Poort SR, Bernardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C Deficiency: A Database of Mutations. For the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 77-84.

van den Besselaar AMPH, Lewis SM, Mannucci PM, Poller L. Status of Present and Candidate International Reference Preparations (IRP) of Thromboplastin for the Prothrombin Time. A Report of the Subcommittee for Control of Anticoagulation. Thromb Haemost 1993; 69: 85.

Edwards RL, Silver J, Rickles FR. Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.

von Kries R, Hanawa Y. Neonatal Vitamin K Prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993; 69: 293-5.

Vol 68 (1992)

Mannucci PM. Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease. Thromb Haemost 1994; 68: 84-7.

Pabinger I, Allaart CF, Hermans J, Briët E, Bertina RM. the Protein C Transmitter Study Group. Hereditary Protein C Deficiency: Laboratory Values in Transmitters and Guidelines for the Diagnostic Procedure. Report on a Study of the SSC Subcommittee on Protein C and Protein S. Thromb Haemost 1992; 68: 470-4.

Boissel JP, Bossard N. Registry of Multicenter Clinical Trials. Twelfth and Thirteenth Report. 1990-1991. Thromb Haemost 1992; 68: 752-78.

Vol 67 (1992)

Peake I. Registry of DNA Polymorphisms Within or Close to the Human Factor VIII and Factor IX Genes. For the Factor VIII/IX Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1992; 67: 277-80.

Schmidt B, Andrew M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost 1979; 67: 381-2.

Vol 66 (1991)

Smith SV, Brinkhous KM. Inventory of Exogenous Platelet Aggregating Agents Derived from Venoms. Thromb Haemost 1991; 66: 259-63.

Pirkle H, Marsh N. Nomenclature of Exogenous Hemostatic Factors. Thromb Haemost 1991; 66: 264.

Boissel JP, Bossard N. Registry of Multicenter Clinical Trials. Eleventh Report--1989. Thromb Haemost 1991; 66: 368-83.

Morfini M, Lee M, Messori A. The Design and Analysis of Half-Life and Recovery Studies for Factor VIII and Factor IX. Thromb Haemost 1991; 66: 384-6.

Vol 65 (1991)

Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for Testing and Revised Criteria for Lupus Anticoagulants SSC. Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-22.

Hathaway W, Corrigan J. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis. Normal Coagulation Data for Fetuses and Newborn Infants. Thromb Haemost 1991; 65: 323-25.

Markland FS, Jr. Inventory of a- and b-Fibrinogenases from Snake Venoms For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 438-43.

Pirkle H, Stocker K. Thrombin-Like Enzymes from Snake Venoms: An Inventory For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 444-50.

Teng CM, Huang TF. Inventory of Exogenous Inhibitors of Platelet Aggregation. For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 624-6.

Rosing J, Tans G. Inventory of Exogenous Prothrombin Activators. For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 627-30.

Bussel J, Kaplan C, McFarland J, and the Working Party of the ISTH. Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia. Thromb Haemost 1991; 65: 631-4.

Vol 64 (1990)

Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-1 (ISLA-1). Thromb Haemost 1990; 64: 478-84.

Pannekoek H, Lijnen HR, Loskutoff DJ. Recommendations for the Nomenclature of Mutant Fibrinolytic Genes and Their Proteins. Thromb Haemost 1990; 64: 600-3.

Vov 63 (1990)

Edwards RL, Morgan DL, Rickles FR. Animal Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1990; 63: 133-138.

Van den Besselaar AMHP. Recommended Method for Reporting Therapeutic Control of Oral Anticoagulant Therapy. Thromb Haemost 1990; 63:316-317.

Vol 62 (1989)

Owen J. The Utility of Plasma Fibrinopeptide Assays. Thromb Haemost 1989; 62: 807-10.

Brettler DB. Guidelines for SSC Communications--Proposed Protocol for the Evaluation of the Effect of High Purity Factor Concentrates on the Immune System of Hemophilia Patients. Thromb Haemost 1989; 62: 811-2.

Francis CW, Mosesson MW. Terminology for Fibrinogen g-Chains Differing in Carboxyl Terminal Amino Acid Sequence. Thromb Haemost 1989; 62: 813-4.

Boissel JP. Subcommittee on Clinical Trials. Registry of Multicenter Clinical Trials. Tenth Report--1988. Thromb Haemost 1989; 62: 1126-42.

Vol 61 (1989)

Zacharski LR, Donati MB. Registry of Clinical Trials of Antithrombotic Drugs in Cancer. Thromb Haemost 1989; 61: 526-8.

Marlar RA, Montgomery RR, Broekmans AW. Report on the Diagnosis and Treatment of Homozygous Protein C Deficiency. Thromb Haemost 1989; 61: 529-31.

Mannucci PM, Colombo M. Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor Concentrates. Thromb Haemost 1989; 61: 532-4.

Membership Management Software Powered by YourMembership  ::  Legal